A weight-loss drug that could be relevant to a large share of the workforce is another
Rockefeller scientists Bruce McEwen and Carla Nasca, in collaboration with Natalie Rasgon, psychiatry professor at the Stanford University School of Medicine, show that patients with a particular type of depression have decreased blood levels of the molecule acetyl-L-carnitine (LAC)a finding that may lead to improved diagnosis and treatment of major depressive disorder (MDD)
Tibon NS, Ng CH, Cheong SL (2020) Current progress in antimalarial pharmacotherapy and multi-target drug discovery
In SOD1 G93A mice, CuII (atsm) improves survival by 26% (Hilton et al., 2017) and was therefore more effective than riluzole (3% survival improvement) in this model (Mcallum et al., 2013
Blocking PD-L1PD-1 improves senescence surveillance and ageing phenotypes
For most appropriately selected patients, the benefits outweigh the risks